Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Deconstructing the Clonal Advantage and Clonal Stability of 5q- Candidate Genes in Del(5q) MDS on a Single Cell Level

Ursula S.A. Stalmann, MD, Fabio Ticconi, MSc, Ronghui Li, MSc, Aaron B. Wong, PhD, Glenn Cowley, PhD, David E. Root, PhD, Dirk Heckl, PhD, Inge Snoeren, MSc, Sergio Martinez, PhDMSc, Tim H Brümmendorf, MD, Andreas Schuppert, PhD, Ivan Costa, PhD, Benjamin L. Ebert, MD PhD, Rebekka K. Schneider, MD PhD

Blood (2019) 134 (Supplement_1): 559.

https://doi.org/10.1182/blood-2019-122588

Published: 2019

Journal Articles

Next Generation CRISPR Gene-Edited and Off-the-Shelf Virus-Specific T-Cells for the Immunocompromised Patient

Blood (2019) 134 (Supplement_1): 1944.

https://doi.org/10.1182/blood-2019-125276

Published: 2019

Journal Articles

A Locus on Chromosome 5 Is Associated with Red Cell Allo-Immunization in Adults with Sickle Cell Disease

Zhengyuan Wang, PhD, Chia-Hao Liu, PhD, Kathleen Vaughan, BA, Caterina Minniti, MD, Lena Diaw, PhD, James G. Taylor, MD

Blood (2017) 130 (Supplement 1): 956.

https://doi.org/10.1182/blood.V130.Suppl_1.956.956

Published: 2017

Journal Articles

Frequency and Clinical Impact of Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5q)

Zuzana Zemanova, PhD, Kyra Michalova, PhD, Jana Brezinova, PhD, Karla Svobodova, Halka Lhotska, Iveta Sarova, PhD, Libuse Lizcova, PhD, Silvia Izakova, Sarka Ransdorfova, PhD, Lenka Pavlistova, PhD, Adela Berkova, PhD, Karolina Skipalova, Monika Belickova, PhD, Magda Siskova, MD, Radana Neuwirtova, MD PhD, Jaroslav Cermak, MD PhD, Tomas Stopka, MD PhD, Anna Jonasova, MD PhD

Blood (2016) 128 (22): 1982.

https://doi.org/10.1182/blood.V128.22.1982.1982

Published: 2016

Journal Articles

Experience of Conventional Cytogenetics in Elderly Cytopenic Indian Patients Suspected with Myelodysplastic Syndromes

Bani Bandana Ganguly, PhD, Mandal Shouvik, MD, Nitin N Kadam, MD, Debasis Banerjee, MD, Sharmila Chandra, MD, Tuphan Kanti Dolai, MD, Mohan Agarwal, MDMNAMS

Blood (2016) 128 (22): 5488.

https://doi.org/10.1182/blood.V128.22.5488.5488

Published: 2016

Journal Articles

Combining Effects of the SMO Inhibitor and Jak1 Inhibitor in Terminal Differentiation of MDS-Derived Induced Potent Stem Cells (iPSC)

Tetsuzo Tauchi, MDPhD, Seiichi Okabe, MD PhD, Seiichiro Katagiri, MD, Yuko Tanaka, MDPhD, Kazuma Ohyashiki, MD PhD

Blood (2016) 128 (22): 3150.

https://doi.org/10.1182/blood.V128.22.3150.3150

Published: 2016

Journal Articles

Targeting the Hedgehog Signaling Pathway By PF-04449913 Limits the Self-Renewal of MDS-Derived Induced Potent Stem Cells (iPSC): Molecular Mechanisms

Tetsuzo Tauchi, MDPhD, Seiichi Okabe, MD PhD, Seiichiro Katagiri, MD, Yuko Tanaka, MDPhD, Kaoru Tohyama, MD PhD, Kazuma Ohyashiki, MD PhD

Blood (2015) 126 (23): 791.

https://doi.org/10.1182/blood.V126.23.791.791

Published: 2015

Journal Articles

SQSTM1/p62 Is a Necessary Cofactor In MDS/AML With Deletion Of Mir-146a

Jing Fang, MD/PhD, Brenden Barker, BSc, Lyndsey Bolanos, BSc, Xiaona Liu, BSc, Andres Jerez, MD, PhD, Hideki Makishima, MD, PhD, Dinesh S. Rao, M.D., James C. Mulloy, PhD, Jaroslaw P. Maciejewski, MD, PhD, Jose A. Cancelas, M.D. PhD., Daniel T Starczynowski, PhD

Blood (2013) 122 (21): 747.

https://doi.org/10.1182/blood.V122.21.747.747

Published: 2013

Journal Articles

A Family Of G-Rich Genomic Sequences Iinteract Specifically With The Pu27 Silencer Element Of The c-Myc Promoter

Shelia Thomas, MS, Francine Rezzoug, PhD, Donald Max Miller, MD, PhD

Blood (2013) 122 (21): 1264.

https://doi.org/10.1182/blood.V122.21.1264.1264

Published: 2013

Journal Articles

Hspa9 Haploinsufficiency Induces a Cell-Intrinsic Defect in Mouse B-Cell Progenitors

Kilannin Krysiak, BS, Justin Tibbitts, MS MBA, Tim H Chen, PhD, Matthew J. Walter, MD

Blood (2012) 120 (21): 1714.

https://doi.org/10.1182/blood.V120.21.1714.1714

Published: 2012

Journal Articles

Association of MDM2 G ene Polymorphisms SNP285 and 309 with Myelodysplastic Syndromes (MDS) Susceptibility and Outcome.

Blood (2012) 120 (21): 2823.

https://doi.org/10.1182/blood.V120.21.2823.2823

Published: 2012

Journal Articles

MLLT10 Gene Promiscuity Unravels Involvement of RNA Processing Genes in Pediatric T-Acute Lymphoblastic Leukemia

Lucia Brandimarte, Valentina Pierini, Danika Di Giacomo, Paolo Gorello, Caterina Matteucci, Marco Giordan, Giovanni Cazzaniga, Geertruy te Kronnie, Roberta La Starza, Cristina Mecucci

Blood (2012) 120 (21): 1431.

https://doi.org/10.1182/blood.V120.21.1431.1431

Published: 2012

Journal Articles

The Type of Genetic Abnormalities Causing Loss of 5q Varies Between MDS and AML and Is Associated with Worse Prognosis in MDS

Claudia Haferlach, MD, Vera Grossmann, MSc, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2012) 120 (21): 697.

https://doi.org/10.1182/blood.V120.21.697.697

Published: 2012

Journal Articles

Leukemogenic Transformation of Hematopoietic Cells by Constitutive Activation of Canonical Wnt Signaling in Osteoblast Precursors

Aruna Kode, Sanil Manavalan, Ioanna Mossialou, Govind Bhagat, MBBS, Murty Vundavalli, Ronald DePinho, Julie Teruya-Feldstein, MD, Ellin Berman, MD, Stavroula Kousteni, PhD

Blood (2012) 120 (21): 509.

https://doi.org/10.1182/blood.V120.21.509.509

Published: 2012

Journal Articles

Hyperhaploid Multiple Myeloma (MM): A Rare Karyotypic Subgroup Retaining Disomy 18 and 1q12∼23 Amplification

Jeffrey Sawyer, Erming Tian, Christoph Heuck, MD, Qing Zhang, Janet Lukacs, Regina Lichti Binz, Edward Thomas, Gael Sammartino, Charles Swanson, Sarah Waheed, MD, Saad Z Usmani, MD FACP, Frits van Rhee, MD, PhD, Bart Barlogie, MD

Blood (2012) 120 (21): 3983.

https://doi.org/10.1182/blood.V120.21.3983.3983

Published: 2012

Journal Articles

B-Cell Progenitors Are Reduced in Hspa9 haploinsufficient Mice,

Kilannin Krysiak, Tim H Chen, PhD, Justin Tibbitts, Michael G. Martin, MD, Matthew J. Walter, MD

Blood (2011) 118 (21): 3829.

https://doi.org/10.1182/blood.V118.21.3829.3829

Published: 2011

Journal Articles

Evaluation of a-Catenin(CTNNA1) As a Tumor Suppressor Gene in Acute Myeloid Leukemis

Xianwei Zeng, MD, PHD, Ya Liu, MD, Cui Lv, MD, Zhenbo Hu, MD

Blood (2011) 118 (21): 5240.

https://doi.org/10.1182/blood.V118.21.5240.5240

Published: 2011

Journal Articles

Analysis of Clonal Cytogenetic Abnormalities in 143 Patients with Secondary AML/MDS

Elena V Domracheva, MD, PhD, Elena A Aseeva, PhD, Galina A Alimova, MD, Olga S Kremenetskaya, PhD, Liubov A Shishigina, Alla I Udovichenko, MD, PhD, Valeri G Savchenko, MD, PhD

Blood (2011) 118 (21): 1473.

https://doi.org/10.1182/blood.V118.21.1473.1473

Published: 2011

Journal Articles

Clinical Characterization, Prognostic Implications, and Response to Therapy In Patients with Myelodysplastic Syndrome (MDS) and Chromsome 17 Abnormality: A Single Institutional Experience

Tapan Kadia, MD, Gautam Borthakur, MD, Stefan Faderl, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Susan O'Brien, MD, Elias Jabbour, MD, Xiao Qin Dong, Sherry A. Pierce, RN, BS, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD

Blood (2010) 116 (21): 2930.

https://doi.org/10.1182/blood.V116.21.2930.2930

Published: 2010

Journal Articles

Detection of Novel Mutations In MDS/AML by Whole Genome Sequencing

Blood (2010) 116 (21): 299.

https://doi.org/10.1182/blood.V116.21.299.299

Published: 2010

NARROW

Deconstructing the Clonal Advantage and Clonal Stability of 5q- Candidate Genes in Del(5q) MDS on a Single Cell Level

Next Generation CRISPR Gene-Edited and Off-the-Shelf Virus-Specific T-Cells for the Immunocompromised Patient

A Locus on Chromosome 5 Is Associated with Red Cell Allo-Immunization in Adults with Sickle Cell Disease

Frequency and Clinical Impact of Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5q)

Experience of Conventional Cytogenetics in Elderly Cytopenic Indian Patients Suspected with Myelodysplastic Syndromes

Combining Effects of the SMO Inhibitor and Jak1 Inhibitor in Terminal Differentiation of MDS-Derived Induced Potent Stem Cells (iPSC)

Targeting the Hedgehog Signaling Pathway By PF-04449913 Limits the Self-Renewal of MDS-Derived Induced Potent Stem Cells (iPSC): Molecular Mechanisms

SQSTM1/p62 Is a Necessary Cofactor In MDS/AML With Deletion Of Mir-146a

A Family Of G-Rich Genomic Sequences Iinteract Specifically With The Pu27 Silencer Element Of The c-Myc Promoter

Hspa9 Haploinsufficiency Induces a Cell-Intrinsic Defect in Mouse B-Cell Progenitors

Association of MDM2 G ene Polymorphisms SNP285 and 309 with Myelodysplastic Syndromes (MDS) Susceptibility and Outcome.

MLLT10 Gene Promiscuity Unravels Involvement of RNA Processing Genes in Pediatric T-Acute Lymphoblastic Leukemia

The Type of Genetic Abnormalities Causing Loss of 5q Varies Between MDS and AML and Is Associated with Worse Prognosis in MDS

Leukemogenic Transformation of Hematopoietic Cells by Constitutive Activation of Canonical Wnt Signaling in Osteoblast Precursors

Hyperhaploid Multiple Myeloma (MM): A Rare Karyotypic Subgroup Retaining Disomy 18 and 1q12∼23 Amplification

B-Cell Progenitors Are Reduced in Hspa9 haploinsufficient Mice,

Evaluation of a-Catenin(CTNNA1) As a Tumor Suppressor Gene in Acute Myeloid Leukemis

Analysis of Clonal Cytogenetic Abnormalities in 143 Patients with Secondary AML/MDS

Clinical Characterization, Prognostic Implications, and Response to Therapy In Patients with Myelodysplastic Syndrome (MDS) and Chromsome 17 Abnormality: A Single Institutional Experience

Detection of Novel Mutations In MDS/AML by Whole Genome Sequencing

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only